Article Versions Notes

Sebastião AI, Mateus D, Carrascal MA, Sousa C, Cortes L, Bachmann MF, do Carmo A, Matos AM, Sales MGF, Cruz MT. CuMV VLPs Containing the RBM from SARS-CoV-2 Spike Protein Drive Dendritic Cell Activation and Th1 Polarization. Pharmaceutics. 2023; 15(3):825. https://doi.org/10.3390/pharmaceutics15030825

Sebastião, Ana Isabel, Daniela Mateus, Mylène A. Carrascal, Cátia Sousa, Luísa Cortes, Martin F. Bachmann, Anália do Carmo, Ana Miguel Matos, Maria Goreti F. Sales, and Maria Teresa Cruz. 2023. "CuMV VLPs Containing the RBM from SARS-CoV-2 Spike Protein Drive Dendritic Cell Activation and Th1 Polarization" Pharmaceutics 15, no. 3: 825. https://doi.org/10.3390/pharmaceutics15030825

Sebastião, A. I., Mateus, D., Carrascal, M. A., Sousa, C., Cortes, L., Bachmann, M. F., do Carmo, A., Matos, A. M., Sales, M. G. F., & Cruz, M. T. (2023). CuMV VLPs Containing the RBM from SARS-CoV-2 Spike Protein Drive Dendritic Cell Activation and Th1 Polarization. Pharmaceutics, 15(3), 825. https://doi.org/10.3390/pharmaceutics15030825